Santa Cruz Biotechnology

SP-100 (1G6) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; SP-100 Antibody (1G6) is an IgG2a κ mouse monoclonal SP-100 antibody (also designated SP-100 antibody) that detects the SP-100 protein of human origin by WB, IP and ELISA. SP-100 Antibody (1G6) is available as the non-conjugated anti-SP-100 antibody. The human SP100 gene encodes an autoantigen that co-localizes with PML and NDP52 in distinct nuclear domains, called nuclear dots (NDs) or ND10 nuclear bodies. Papova-, adeno-, and herpesviruses begin their transcription and DNA-replication at NDs, which play a role in autoimmunity, viral infections and in the etiology of acute promyelocytic leukemia. SP-100 is an interferon-inducible protein that has two splice variants. One splice variant contains a highly conserved copy of the DNA-binding high mobility group 1 protein sequence, and thus represents a novel HMG-box protein. This alternatively spliced variant of SP-100 has a unique expression and localization pattern that is distinct from the SP-100 full-length protein. The SP100 protein is covalently modified by the small ubiquitin-related protein SUMO-1. SP-100 contains a functional nuclear localization signal and an ND-targeting region, which overlaps with the SP-100 homodimerization domain. The homodimerization/ND-targeting region is considered a novel protein motif, termed HSR domain. SP-100 is also found to interact with Bright (B cell regulator of IgH transcription), which in lymphoid cells also interacts with LYSP100/SP140, the lymphoid-restricted homolog of SP100.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.